Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Nascent Biotech Inc. (NBIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/14/2023 |
8-K
| Quarterly results |
| 05/09/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Nascent Biotech to Present Phase I Clinical Data at American Society of Clinical Oncology Annual Meeting NORTH PALM BEACH, FL, May 9, 2023 - Nascent Biotech, Inc. , a clinical-stage biotechnology Company whose business is focused in therapeutic monoclonal antibody space, announced today that the Company has been selected for a poster presentation at the American Society of Clinical Oncology 2023 Annual Meeting held in Chicago on June 2-6, 2023. The poster presentation, entitled ”Phase I Study of Pritumumab in Brain Cancer”, will take place from 1:15-4:15 PM CDT on June 3rd , during the ”Central Nervous Systems Tumors” session in Hall A of McCormick Place Convention Center. ASCO is the largest clinical oncology conference that brings together cancer leaders from across the globe to discuss ..." |
|
| 09/28/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 09/20/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 09/09/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 09/06/2022 |
8-K/A
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 09/02/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 08/17/2021 |
8-K
| Other Events |
| 06/17/2021 |
8-K
| Quarterly results |
| 05/11/2021 |
8-K
| Quarterly results |
| 04/26/2021 |
8-K
| Quarterly results |
| 04/14/2021 |
8-K
| Quarterly results |
| 03/24/2021 |
8-K
| Quarterly results |
| 12/09/2020 |
8-K
| Other Events |
| 11/04/2020 |
8-K
| Other Events |
| 09/22/2020 |
8-K
| Quarterly results |
| 07/13/2020 |
8-K
| Quarterly results |
| 05/13/2020 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 04/27/2020 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 03/05/2020 |
8-K
| Quarterly results |
| 12/10/2019 |
8-K
| Quarterly results |
| 09/06/2019 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 08/15/2019 |
8-K
| Quarterly results |
| 12/10/2018 |
8-K
| Regulation FD Disclosure |
| 11/06/2018 |
8-K
| Other Events |
| 01/25/2018 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
| 11/02/2017 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits|
Docs:
|
"EXHIBIT 99i Nascent Biotech Announces the Completion of $1,451,000 Private Equity Raise. Thursday November 2, 2017 Dateline: Vero Beach, FL, USA Vero Beach, FL, USA. - Nascent Biotech, Inc. , today announced the completion of a $1,451,000 in private equity raises consisting of a combination of common stock and warrants. The first tranche of $305,000 closed in February 2017 and the second tranche of $1,146,000 closed in September, 2017. Nascent President and CEO Sean Carrick said, “We are very pleased to have completed this round of Financing.” Mr. Carrick also stated, “The financing just completed is scheduled to provide the Company with funds required through IND clearance and into the preparation for Phase 1 human clinical studies.” Nascent previously received orphan drug designations fr..." |
|
| 10/06/2017 |
8-K
| Quarterly results |
| 08/09/2017 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 04/05/2017 |
8-K
| Form 8-K - Current report |
| 11/14/2016 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 07/19/2016 |
8-K
| Form 8-K - Current report |
| 04/11/2016 |
8-K
| Form 8-K - Current report |
| 01/05/2016 |
8-K
| Form 8-K - Current report |
|
|
|